Ionis (IONS) EVP/CSO Bennett C. Frank Buys 110 Shares

What Happened

Bennett C. Frank, EVP and Chief Scientific Officer of Ionis Pharmaceuticals (IONS), acquired 110 shares on August 31, 2026 at $51.31 per share, for a total cost of $5,644. The transaction is reported as code "J" (other acquisition or disposition) and reflects a purchase through the company's employee stock purchase plan.

Key Details

• Transaction date and price: 2026-08-31 — 110 shares at $51.31 each.
• Total value: approximately $5,644.
• Filing date: 2026-09-02 (reported two days after the transaction; Form 4 is generally due within two business days).
• Shares owned after transaction: not specified in the filing excerpt.
• Footnote: These shares were purchased under the Ionis Amended and Restated 2000 Employee Stock Purchase Plan and may not be sold until February 28, 2027 (per footnote F1).

Context

This was a purchase through an employee stock purchase plan (ESPP), a routine way employees buy company shares, often on favorable terms and subject to holding restrictions. The amount is relatively small (~$5.6k) compared with typical executive holdings; such ESPP purchases are informative but do not, by themselves, indicate a change in insider sentiment.